Tag: ARVs for prevention

Projects

• Motivations and barriers to PrEP use for black men who have sex with men (MSM), aged 18-45 in London (2016-2016)
• Being negative: gay men, sex, love and risk (2015-2016)
• HIV and biomedical prevention in the UK: re-framing the social science agenda (2012-2012)
• PEP talk: awareness of, and access to post-exposure prophylaxis among gay men and bisexual men in the UK (2005-2006)

Final reports

• The EMIS Network. EMIS-2017 – The European Men-Who-Have-Sex-With-Men Internet Survey. Key findings from 50 countries.
  Stockholm, European Centre for Disease Prevention and Control, 2019 (ISBN 978-92-9498-341-1).
• PEP talk: awareness of, and access to post-exposure prophylaxis among gay and bisexual men in the UK
  Sigma Research, 2006 (ISBN 1 872956 84 X)

Local reports

• EMIS-2017 National Reports
  
• 1st EMIS-2017 Community Report
  

Journal articles

• Estimating the ‘PrEP Gap’: how implementation and access to PrEP differ between countries in Europe and Central Asia in 2019
  Eurosurveillance, 2019; 24(41) (doi: 10.2807/1560-7917).
• Understanding user perspectives of and preferences for oral PrEP for HIV prevention in the context of intervention scale-up: a synthesis of evidence from sub-Saharan Africa
  Journal of the International AIDS Society, 2019 July, 22(S4):e25306 (doi: 10.1002/jia2.25306)
• What qualities in a potential HIV pre-exposure prophylaxis service are valued by black men who have sex with men in London? A qualitative acceptability study
  International Journal of STD & AIDS, 2018; 29(8): 760–765 (doi:10.1177/0956462418755224).
• Non-condom related strategies to reduce the risk of HIV transmission: Perspectives and experiences of gay men with diagnosed HIV
  Journal of Health Psychology, 2016; 21(11):2562-2571 (doi:10.1177/1359105315581066).
• Protocol for a systematic review: understanding the motivations and barriers to uptake and use of female-initiated, primary biomedical HIV prevention technologies in sub-Saharan Africa
  Systematic Reviews, 2015, 4:111 (doi:10.1186/s13643-015-0096-1)
• Pharmaceutical HIV prevention technologies in the UK: six domains for social science research
  AIDS Care, 2015, 27:6, 796-803 (doi:10.1080/09540121.2014.989484).
• Positive benefits: preventive impact of post-exposure prophylaxis awareness among those with diagnosed HIV
  Sexually Transmitted Infections, 2008, 84:92-93 (doi:10.1136/sti.2007.026211).

Presentations

• Prevalence of PrEP use and modes of access in 42 European countries, Lebanon, Israel and Canada
  (Axel J. Schmidt)
  AIDS Impact, London, England, 31 July 2019
• European MSM Internet Survey 2017: Response, Demographics, Chemsex, PrEP
  (Axel J. Schmidt & Peter Weatherburn)
  22nd International AIDS Conference (AIDS 2018), Amsterdam, Netherlands, July 23-27, 2018
• Motivations and barriers to pre-exposure prophylaxis (PrEP) use among black men who have sex with men (MSM) aged 18-45 in London
  (Charlie Witzel)
  After PrEP: Ethical Sexualities, Viral Memories, and New Socio-Medical Landscapes in HIV Prevention, University of Sussex, 2-3 June 2016
• ARVs for prevention: a research agenda for the social sciences
  (Catherine Dodds, Adam Bourne, Peter Weatherburn and others)
  IAPAC Controlling the HIV Epidemic with Antiretrovirals, London, 22-24 September 2013 (Plenary)
• Professional ambivalence: the views of HIV service providers about ARVs for prevention in 3 settings
  (Catherine Dodds, Asha Persson, E. Vernooijc)
  IAPAC Controlling the HIV Epidemic with Antiretrovirals, London, 22-24 September 2013 (Poster).
• Perceptions of HIV treatment as prevention among African people in sero-discordant relationships
  (Adam Bourne, Catherine Dodds; Jabulani Chwaula; Peter Weatherburn)
  XIX International AIDS Conference, Washington D.C, 25 July 2012 (Poster).